EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accurate serotype identification of Streptococcus pneumoniae using nanopore Cas9-targeted serotype identification (nCATSerotyping)

Hyun Jung Ji iD, A-Yeung Jang, Seung Hyun Han iD, Min-Kyu Kim iD, Charles Euloge Lamien, Viskam Wijewardana, Ki Bum Ahn, Kyung-Hyo Kim, Joon Young Song iD, Ho Seong Seo iD

Journal of Clinical Microbiology · 2026

DOI: 10.1128/jcm.00984-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von Hyun Jung Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Serotyping, Pneumococcal Infections, Nanopore Sequencing. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Food and Drug Safety, Korea Disease Control and Prevention Agency, Korea Atomic Energy Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus pneumoniae (pneumococcus) is a leading cause of community-acquired pneumonia and invasive diseases, particularly among children and the elderly. The introduction of pneumococcal conjugate vaccines has significantly reduced invasive pneumococcal disease, but the prevalence of non-vaccine serotypes and newly emerging serotypes is increasing globally. Thus, accurate serotyping is essential for epidemiological surveillance and the development of next-generation multivalent pneumococcal vaccines. Conventional serotyping methods, including multiplex polymerase chain reaction (mPCR), monoclonal antibody (mAb) assays, and Quellung reaction using rabbit antisera, are limited by serotype coverage and cross-reactivity, making the detection of new or emerging serotypes challenging. In this study, we developed a nanopore Cas9-targeted serotyping (nCATSerotyping) platform, which employs Cas9-mediated enrichment of the capsular polysaccharide synthesis locus followed by Oxford Nanopore sequencing. Applying this method to 276 clinical pneumococcal isolates collected in South Korea (2018–2020), we achieved a serotyping success rate of 97.10% (268/276), significantly outperforming conventional methods such as mAb and mPCR, which identified only 76.45% (211/276) of isolates. Whole-genome sequencing of the remaining eight non-typeable isolates revealed them to be non-pneumococcal (oral streptococci), confirming 100% accuracy for S. pneumoniae serotyping. Importantly, our method identified emerging and underrepresented serotypes, including serotype 13 and null capsule clade strains. nCATSerotyping offers a rapid, accurate, and comprehensive solution for pneumococcal serotyping, with significant advantages in identifying novel and non-typeable strains. This scalable platform will be a valuable tool for global serotype surveillance and next-generation multivalent pneumococcal vaccine development. IMPORTANCE Accurate pneumococcal serotyping is critical for vaccine development and epidemiological surveillance, particularly as non-vaccine serotypes emerge following widespread pneumococcal conjugate vaccine implementation. Current serotyping methods face significant limitations in coverage and accuracy, identifying around 76% of pneumococcal isolates and failing to detect emerging serotypes like serotype 13 and null capsule clades. The nanopore Cas9-targeted serotyping platform addresses these critical gaps by achieving 100% serotyping accuracy for confirmed Streptococcus pneumoniae isolates while identifying previously undetectable strains that conventional methods missed. This comprehensive approach is essential for monitoring vaccine effectiveness, understanding serotype replacement patterns, and informing next-generation vaccine development strategies. Furthermore, the identification of misclassified oral streptococci highlights the diagnostic precision needed for accurate pneumococcal surveillance, ensuring that epidemiological data accurately reflect true pneumococcal disease burden and serotype distribution patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaeSerotypingPneumococcal InfectionsNanopore SequencingHumansSerogroupRepublic of KoreaCRISPR-Cas SystemsPneumococcal Vaccines

Stichwörter der Autor:innen

CRISPR-Cas9Streptococcus pneumoniaeemerging serotypesnanopore sequencingserotypingvaccine development

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • Research Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Department of Oral Microbiology and Immunology, DRI, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
  • Division of Infectious Disease, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of Korea.
  • Department of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency, Seibersdorf, Austria.
  • Department of Pediatrics, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.

ORCID-Profile: Hyun Jung Ji, Seung Hyun Han, Min-Kyu Kim, Joon Young Song, Ho Seong Seo

Förderung

  • Ministry of Food and Drug Safety
  • Korea Disease Control and Prevention Agency
  • Korea Atomic Energy Research Institute
  • National Research Foundation of Korea
  • International Atomic Energy Agency

Zitieren

APA

Ji, H. J., Jang, A. Y., Han, S. H., Kim, M. K., Lamien, C. E., Wijewardana, V., Ahn, K. B., Kim, K. H., Song, J. Y., & Seo, H. S. (2026). Accurate serotype identification of Streptococcus pneumoniae using nanopore Cas9-targeted serotype identification (nCATSerotyping). Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00984-25

Vancouver

Ji HJ, Jang AY, Han SH, Kim MK, Lamien CE, Wijewardana V, et al. Accurate serotype identification of Streptococcus pneumoniae using nanopore Cas9-targeted serotype identification (nCATSerotyping). Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.00984-25

BibTeX
@article{Ji2026,
  author = {Ji, Hyun Jung and Jang, A-Yeung and Han, Seung Hyun and Kim, Min-Kyu and Lamien, Charles Euloge and Wijewardana, Viskam and Ahn, Ki Bum and Kim, Kyung-Hyo and Song, Joon Young and Seo, Ho Seong},
  title = {Accurate serotype identification of Streptococcus pneumoniae using nanopore Cas9-targeted serotype identification (nCATSerotyping)},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  doi = {10.1128/jcm.00984-25}
}
Kostenlos starten →